Senseonics' (SENS) Eversense 365 is approved in the US as an integrated continuous glucose monitoring (iCGM) system for people with Type 1 and Type 2 diabetes aged 18 and older Commercial launch by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback